148 related articles for article (PubMed ID: 37416330)
1. Resection cavity dynamics and optimal timing of adjuvant stereotactic radiosurgery for resected brain metastases.
Rajkumar S; Liang Y; Shepard MJ; Williamson R; Yu A; Karlovits SM; Rodney EW
J Radiosurg SBRT; 2022; 8(4):247-255. PubMed ID: 37416330
[TBL] [Abstract][Full Text] [Related]
2. Preoperative stereotactic radiosurgery before planned resection of brain metastases: updated analysis of efficacy and toxicity of a novel treatment paradigm.
Prabhu RS; Miller KR; Asher AL; Heinzerling JH; Moeller BJ; Lankford SP; McCammon RJ; Fasola CE; Patel KR; Press RH; Sumrall AL; Ward MC; Burri SH
J Neurosurg; 2018 Dec; 131(5):1387-1394. PubMed ID: 30554174
[TBL] [Abstract][Full Text] [Related]
3. Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control.
Iorio-Morin C; Masson-Côté L; Ezahr Y; Blanchard J; Ebacher A; Mathieu D
J Neurosurg; 2014 Dec; 121 Suppl():69-74. PubMed ID: 25434939
[TBL] [Abstract][Full Text] [Related]
4. Surgical Resection of Brain Metastases and the Risk of Leptomeningeal Recurrence in Patients Treated With Stereotactic Radiosurgery.
Johnson MD; Avkshtol V; Baschnagel AM; Meyer K; Ye H; Grills IS; Chen PY; Maitz A; Olson RE; Pieper DR; Krauss DJ
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):537-43. PubMed ID: 26867883
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic radiosurgery to surgical cavity post resection of brain metastases: Local recurrence and overall survival rates. A single-centre experience.
Higgins MJ; Burke O; Fitzpatrick D; Nugent KG; Skourou C; Dunne M; Javadpour M; Faul C
J Med Imaging Radiat Oncol; 2018 Oct; 62(5):726-733. PubMed ID: 30044047
[TBL] [Abstract][Full Text] [Related]
6. Outcome comparison of patients who develop leptomeningeal disease or distant brain recurrence after brain metastases resection cavity radiosurgery.
Teyateeti A; Brown PD; Mahajan A; Laack NN; Pollock BE
Neurooncol Adv; 2021; 3(1):vdab036. PubMed ID: 33860228
[TBL] [Abstract][Full Text] [Related]
7. Impact of regular magnetic resonance imaging follow-up after stereotactic radiotherapy to the surgical cavity in patients with one to three brain metastases.
Bachmann N; Leiser D; Ermis E; Vulcu S; Schucht P; Raabe A; Aebersold DM; Herrmann E
Radiat Oncol; 2019 Mar; 14(1):45. PubMed ID: 30871597
[TBL] [Abstract][Full Text] [Related]
8. Intracranial control and radiographic changes with adjuvant radiation therapy for resected brain metastases: whole brain radiotherapy versus stereotactic radiosurgery alone.
Patel KR; Prabhu RS; Kandula S; Oliver DE; Kim S; Hadjipanayis C; Olson JJ; Oyesiku N; Curran WJ; Khan MK; Shu HK; Crocker I
J Neurooncol; 2014 Dec; 120(3):657-63. PubMed ID: 25189789
[TBL] [Abstract][Full Text] [Related]
9. Comparing pre-operative stereotactic radiosurgery (SRS) to post-operative whole brain radiation therapy (WBRT) for resectable brain metastases: a multi-institutional analysis.
Patel KR; Burri SH; Boselli D; Symanowski JT; Asher AL; Sumrall A; Fraser RW; Press RH; Zhong J; Cassidy RJ; Olson JJ; Curran WJ; Shu HG; Crocker IR; Prabhu RS
J Neurooncol; 2017 Feb; 131(3):611-618. PubMed ID: 28000105
[TBL] [Abstract][Full Text] [Related]
10. A matched-pair analysis of clinical outcomes after intracavitary cesium-131 brachytherapy versus stereotactic radiosurgery for resected brain metastases.
Julie DA; Lazow SP; Vanderbilt DB; Taube S; Yondorf MZ; Sabbas A; Pannullo S; Schwartz TH; Wernicke AG
J Neurosurg; 2020 May; 134(5):1447-1454. PubMed ID: 32413856
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic Cavity Irradiation or Whole-Brain Radiotherapy Following Brain Metastases Resection-Outcome, Prognostic Factors, and Recurrence Patterns.
El Shafie RA; Dresel T; Weber D; Schmitt D; Lang K; König L; Höne S; Forster T; von Nettelbladt B; Eichkorn T; Adeberg S; Debus J; Rieken S; Bernhardt D
Front Oncol; 2020; 10():693. PubMed ID: 32477942
[No Abstract] [Full Text] [Related]
12. Leptomeningeal disease and brain control after postoperative stereotactic radiosurgery with or without immunotherapy for resected brain metastases.
Minniti G; Lanzetta G; Capone L; Giraffa M; Russo I; Cicone F; Bozzao A; Alongi F; Nicosia L; Fineschi G; Marchetti L; Tufo T; Bianciardi F; Esposito V; Gentile P; Paolini S
J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34949695
[TBL] [Abstract][Full Text] [Related]
13. Local control and overall survival for adjuvant stereotactic radiosurgery in patients with residual or recurrent disease.
Nanda T; Yaeh A; Wu CC; Jani A; Saad S; Qureshi YH; Cauley KA; Lesser J; Cheng SK; Isaacson SR; Sisti MB; Bruce JN; McKhann GM; Sheth SA; Lassman AB; Wang TJC
J Neurooncol; 2018 Jan; 136(2):281-287. PubMed ID: 29170908
[TBL] [Abstract][Full Text] [Related]
14. Timing of Adjuvant Fractionated Stereotactic Radiosurgery Affects Local Control of Resected Brain Metastases.
Roth O'Brien DA; Poppas P; Kaye SM; Mahase SS; An A; Christos PJ; Liechty B; Pisapia D; Ramakrishna R; Wernicke AG; Knisely JPS; Pannullo S; Schwartz TH
Pract Radiat Oncol; 2021; 11(3):e267-e275. PubMed ID: 33578001
[TBL] [Abstract][Full Text] [Related]
15. Time to administration of stereotactic radiosurgery to the cavity after surgery for brain metastases: a real-world analysis.
Roth O'Brien DA; Kaye SM; Poppas PJ; Mahase SS; An A; Christos PJ; Liechty B; Pisapia D; Ramakrishna R; Wernicke AG; Knisely JPS; Pannullo SC; Schwartz TH
J Neurosurg; 2021 May; 135(6):1695-1705. PubMed ID: 34049277
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis.
Ojerholm E; Lee JY; Thawani JP; Miller D; O'Rourke DM; Dorsey JF; Geiger GA; Nagda S; Kolker JD; Lustig RA; Alonso-Basanta M
J Neurosurg; 2014 Dec; 121 Suppl():75-83. PubMed ID: 25434940
[TBL] [Abstract][Full Text] [Related]
17. Surgical Cavity Constriction and Local Progression Between Resection and Adjuvant Radiosurgery for Brain Metastases.
Shah JK; Potts MB; Sneed PK; Aghi MK; McDermott MW
Cureus; 2016 Apr; 8(4):e575. PubMed ID: 27226936
[TBL] [Abstract][Full Text] [Related]
18. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic radiosurgery to the resection cavity for brain metastases: prognostic factors and outcomes.
Abel RJ; Ji L; Yu C; Lederman A; Chen T; Liu C; Zada G; Kim PE; Apuzzo M; Chang EL
J Radiosurg SBRT; 2015; 3(3):179-186. PubMed ID: 29296400
[TBL] [Abstract][Full Text] [Related]
20. Cavity volume dynamics after resection of brain metastases and timing of postresection cavity stereotactic radiosurgery.
Atalar B; Choi CY; Harsh GR; Chang SD; Gibbs IC; Adler JR; Soltys SG
Neurosurgery; 2013 Feb; 72(2):180-5; discussion 185. PubMed ID: 23149969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
